Expertise in
3
conditions

Maeva Guillaume

Toulouse, FR 
Expertise in
3
conditions
Toulouse, FR 

Overview

Maeva Guillaume practices practicing medicine in Toulouse, France.

Ms. Guillaume is highly rated in 3 conditions, according to our data. Her clinical expertise encompasses Non-Alcoholic Fatty Liver Disease, Cirrhosis, Portal Hypertension, Oophorectomy, and Hormone Replacement Therapy (HRT).

She is actively involved in clinical research, co-authoring 43 peer reviewed articles and participating in 5 clinical trials.

Gender

Female

Locations

Toulouse, France
Other Locations
Alfortville, France
Rouen, France
CHU
Caen, France
1 Avenue De L'Hôpital, BP 90074, Pringy, 74374, France
Clinique De Médecine Interne Dr Bosseray, BP 217, 38043 Grenoble Cedex 9, Grenoble, 38043, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

Study of Correlation Between Hepatic Fibrosis and Cardiovascular Risk Evaluated by Non-invasive Tests in Patients With Nonalcoholic Fatty Liver Disease
Study of Correlation Between Hepatic Fibrosis and Cardiovascular Risk Evaluated by Non-invasive Tests in Patients With Nonalcoholic Fatty Liver Disease
Enrollment Status: Completed
Publish Date: March 06, 2026
A Phase 3, Double-Blind, Randomized, Long-Term, Placebo-Controlled, Multicenter Study Evaluating the Safety and Efficacy of Obeticholic Acid in Subjects With Nonalcoholic Steatohepatitis
A Phase 3, Double-Blind, Randomized, Long-Term, Placebo-Controlled, Multicenter Study Evaluating the Safety and Efficacy of Obeticholic Acid in Subjects With Nonalcoholic Steatohepatitis
Enrollment Status: Terminated
Publish Date: October 01, 2024
Intervention Type: Drug
Study Drug: Obeticholic Acid
Study Phase: Phase 3
A Phase 3, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Obeticholic Acid in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis
A Phase 3, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Obeticholic Acid in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis
Enrollment Status: Completed
Publish Date: October 23, 2023
Intervention Type: Drug
Study Drug: Obeticholic acid
Study Phase: Phase 3
Evaluation of the Involvement of the Intestinal Microbiota and Choline Deficiency in the Severity of Chronic Liver Disease Explored by Analyzing Collection of Biological Samples
Evaluation of the Involvement of the Intestinal Microbiota and Choline Deficiency in the Severity of Chronic Liver Disease Explored by Analyzing Collection of Biological Samples
Enrollment Status: Completed
Publish Date: July 28, 2021
Using MRI for a Non-invasive Evaluation of Portal Pressure
Using MRI for a Non-invasive Evaluation of Portal Pressure
Enrollment Status: Terminated
Publish Date: August 21, 2019
Intervention Type: Procedure
Study Phase: Not Applicable
View 4 Less Clinical Trials

43 Total Publications

Management of patients with type 2 diabetes and MASLD: An overview and joint statement.
Management of patients with type 2 diabetes and MASLD: An overview and joint statement.
Journal: Diabetes & metabolism
Published: October 02, 2025

Frequently Asked Questions about Maeva Guillaume

Is Maeva Guillaume a top-rated expert for Non-Alcoholic Fatty Liver Disease?

MediFind is an objective health platform that identifies experts based on real-world data. Maeva Guillaume is classified as an Advanced expert for Non-Alcoholic Fatty Liver Disease, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Maeva Guillaume participate in research or clinical trials?

Yes. Maeva Guillaume has published 43 articles and abstracts on conditions like Non-Alcoholic Fatty Liver Disease. You can view a list of Maeva Guillaume's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Guillaume's expertise for a condition
ConditionClose
      View All 19 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile